SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 98 filers reported holding SAGENT PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $3,312,000 | +17.6% | 221,300 | -4.4% | 0.00% | 0.0% |
Q1 2016 | $2,816,000 | -3.8% | 231,598 | +25.8% | 0.00% | 0.0% |
Q4 2015 | $2,927,000 | +188.7% | 184,137 | +177.9% | 0.00% | +100.0% |
Q3 2015 | $1,014,000 | -63.2% | 66,267 | -41.6% | 0.00% | -50.0% |
Q2 2015 | $2,756,000 | +125.3% | 113,445 | +115.4% | 0.00% | +100.0% |
Q1 2015 | $1,223,000 | -44.0% | 52,657 | -39.5% | 0.00% | 0.0% |
Q4 2014 | $2,185,000 | -8.6% | 87,084 | +13.2% | 0.00% | 0.0% |
Q3 2014 | $2,390,000 | +41.1% | 76,924 | +17.4% | 0.00% | 0.0% |
Q2 2014 | $1,694,000 | +232.8% | 65,536 | +199.9% | 0.00% | – |
Q1 2014 | $509,000 | +68.5% | 21,855 | +82.9% | 0.00% | – |
Q4 2013 | $302,000 | -43.8% | 11,952 | -54.7% | 0.00% | – |
Q3 2013 | $537,000 | – | 26,377 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SENZAR ASSET MANAGEMENT, LLC | 453,392 | $11,022,000 | 1.89% |
GREAT POINT PARTNERS LLC | 141,900 | $3,450,000 | 1.34% |
Penn Capital Management Company, LLC | 1,247,428 | $30,325,000 | 1.25% |
Ranger Investment Management | 982,240 | $23,878,000 | 1.16% |
HealthCor Management, L.P. | 912,381 | $22,180,000 | 1.12% |
Piermont Capital Management Inc. | 138,380 | $3,364,000 | 1.02% |
JW Asset Management, LLC | 111,630 | $2,714,000 | 0.82% |
SECTORAL ASSET MANAGEMENT INC | 465,625 | $11,319,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 28,000 | $681,000 | 0.42% |
Tekla Capital Management LLC | 409,500 | $9,955,000 | 0.36% |